GNRH1 and Familial prostate cancer: Interestingly, in this paper we could show, by clonogenic assay, that GnRH agonists, through p53-mediated Bax expression, can resensitize docetaxel-resistant prostate cancer cells, characterized by downregulation of Bax, to the antitumor activity of the chemotherapeutic drug.